2.12. Statistical Analysis
cognitive decline, MCI
The combined analyses of the two trials of composite memory for PPS and those for the subgroup with cognitive decline were performed as the main efficacy assessments. In clinical settings, there is a cutoff value of 25/26 for the MoCA-J for possible MCI [In both trials, PPS and subgroup analyses with cognitive decline (MoCA-J score < 23) were performed for efficacy assessments. For quantitative variables, an unpaired Student’s 